"We Envision Growth Strategies Most Suited
to Your Business"

Diabetic Foot Ulcer Treatment Market Worth USD 11.16 Billion by 2026; Rise in Prevalence of Diabetic Foot Ulcer to Promote Market Growth

January 14, 2020 | Healthcare

The global diabetic foot ulcer (DFU) treatment market size to reach USD 11.16 billion by 2026, on account of the increasing prevalence of diabetes worldwide. According to a new report by Fortune Business Insights™ titled, Diabetic Foot Ulcer (DFU) Treatment Market Size, Share & Industry Analysis, By Ulcer Type (Neuropathic Ulcer, Ischemic Ulcer, Neuro-ischemic Ulcer), By Product (Wound-care Dressings, Wound-care Devices, Active Therapies, and Others), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Homecare Settings), and Regional Forecasts, 2019-2026,” the market value stood at USD 6.62 billion in 2018. Furthermore, the market is expected to exhibit a CAGR of 6.8 % during the forecast period, 2019 – 2026.

Advanced Treatment Options such as Extracellular Matrix Proteins to Aid in Expansion of Market

The rising prevalence of diabetes in the world is a crucial factor responsible for DFU treatment market growth. This, coupled with the increasing adoption of novel wound care devices, is also expected to augment the diabetic foot ulcer treatment market growth. Moreover, there has been continuous investments made for diabetic foot ulcer treatment options such as miscellaneous therapeutic agents, extracellular matrix proteins, skin substitutes, bioengineered skin substitutes, and others. The above factor is likely to help attract high diabetic foot ulcer treatment market revenue in the future years.

To get a detailed report summary and research scope of this market, click here: https://www.fortunebusinessinsights.com/industry-reports/diabetic-foot-ulcer-dfu-treatment-market-101948

Detailed Segmentation of Diabetic Foot Ulcer Treatment Market

Ulcer Type – With respect to ulcer type, the market is categorized into neuroischemic ulcers, ischemic ulcers, and neuropathic ulcers. Out of these, the neuroischemic ulcer segment has earned the largest diabetic foot ulcer market share, attributed to the high treatment cost and rise in prevalence of the disease.

Product –  Based on the product, the diabetic foot ulcer market is segmented into wound care dressings, wound care devices, active therapies, and others. Each segment is further categorized into sub-segments. The wound care dressing segment is holding a dominant diabetic foot ulcer market share on account of increasing adoption of negative pressure wound therapy. In 2018, this segment earned a 42.8% share in the market.

End User – On the basis of end users, the market is classified into clinics, hospitals, ambulatory centers, and home care settings. Among these, the hospital segment accounted for the largest diabetic foot ulcer market share owing to the presence of needed facility, rising patient preference to hospitals owing to favorable policies supported by governments, and the presence of skilled staff.

Region – On a geographical basis, the market is dominated by North America on account of rising in the prevalence of foot ulcers among diabetics, the rise in the launch of advanced technologies and the high cost of products. This is being followed by Europe owing to the adoption of advanced treatment options for diabetic foot ulcers in nations such as France, U.K., and Germany.

Companies to Primarily Focus on Expanding their Geographical Reach

DFU treatment market manufacturers are emphasizing on strengthening their brand presence and are therefore expanding their geographical presence. Besides this, vendors are also offering a wide range of products to attract significant diabetic foot ulcer market revenue in the forthcoming years. Apart from this, companies are also entering into strategic collaborations for launching new products.

Some of the key DFU market manufacturers are as follows:

  • Tissue Regenix

  • Coloplast Corp

  • Cardinal Health.

  • ConvaTec Group Plc

  • Integra LifeSciences Corporation.

  • Smith & Nephew

  • B. Braun Melsungen AG

  • 3M

  • Mölnlycke Health Care, AB.

  • Other Players

Recent key industry developments of diabetic foot ulcer market include:

  • December 2017 – FDA approved Sanuwave Heath Inc. for marketing its first shock wave device called Dermapace System, meant for treating diabetic foot ulcers.

  • July 2018 – A German wound care products vendor SastoMed GmbH was acquired by Mölnlycke. The main objective is to expand their product offerings for accelerating their wound healing process and treating chronic wounds such as diabetic foot ulcers.

  • December 2019 – Orpyx SI Sensory Insoles with remote patient monitoring was launched by Orpyx Medical Technologies Inc. This is mainly used for preventing neuropathy-related ulcers and diabetic foot ulcers.

The global diabetic foot ulcer treatment market is categorized in the following manner:



Study Period


Base Year


Forecast Period


Historical Period



  Value (USD Billion)


By Ulcer Type

  • Neuropathic Ulcer

  • Ischemic Ulcer

  • Neuro-Ischemic Ulcer


By Product Type

  • Wound-care Dressings

    • Antimicrobial Dressing

    • Foam Dressings

    • Film Dressings

    • Alginate Dressings

    • Hydrogel Dressings

    • Other Dressings

  • Wound-care Devices

    • Negative Pressure Wound Therapy (NPWT)

    • Ultrasound Therapy

    • HBOT

    • Others

  • Active Therapies

    • Skin Grafts & Substitutes

    • Growth Factors

    • Others

  • Others

By End User

  • Hospitals

  • Clinics

  • Ambulatory Surgical Centers

  • Homecare Settings

By Geography

  • North America (the U.S. and Canada)

  • Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)

  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific)

  • Latin America (Brazil, Mexico, and the Rest of Latin America)

  • Middle East & Africa (South Africa, GCC, and the Rest of the Middle East & Africa)

Diabetic Foot Ulcer (DFU) Treatment Market
  • PDF
  • 2018
  • 2015-2017
  • 115


  • 4850

Our Clients

We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.